×
0 0 0 0 0 0 0.0131004366812226 0.109170305676856
Stockreport

TG Therapeutics: Promising MS Data [Seeking Alpha]

TG THERAPEUTICS (TGTX)  More Company Research Source: Seeking Alpha
Last tg therapeutics earnings: 8/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF Summary TG Therapeutics (NASDAQ: TGTX ) announced additional promising data of TG-1101 (ublituximab) from its ongoing phase 2 study in patients with relapsing forms of multiple sclerosis (RMS) at the 69th American Academy of Neurology (NYSE: AAN ) annual meeting in Boston, MA, in late April. I initiated coverage on TG Therapeutics back in January (the article is exclusive to Growth Stock Forum subscribers) and this article provides an overview of TG-1101's opportunity in MS. Background - Ocrevus potential to become new standard of care in MS Before delving into '1101's potential, let's take a look at current market dynamics. Roche developed Ocrevus, an anti-CD20 monoclonal antibody, as a replacement for Rituxan, which showed promising efficacy in MS, but Roche never bothered to conduct pivotal trials to expand the label since Rituxan will lose patent protection soon. Rituxan is used off-label for MS but reimbursement can be hard to obtain. Ocrevus is an improved v [Read more]

IMPACT SNAPSHOT EVENT TIME: TGTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
TGTX alerts
from News Quantified
Opt-in for
TGTX alerts

from News Quantified
Opt-in for
TGTX alerts

from News Quantified